These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 7635469)

  • 1. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
    Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
    Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis in Jews: frequency and mutation distribution.
    Kerem B; Chiba-Falek O; Kerem E
    Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.
    Quint A; Lerer I; Sagi M; Abeliovich D
    Am J Med Genet A; 2005 Jul; 136(3):246-8. PubMed ID: 15948195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in frequencies of the cystic fibrosis alleles, delta F508 and W1282X, between carriers and patients.
    Kalman YM; Kerem E; Darvasi A; DeMarchi J; Kerem B
    Eur J Hum Genet; 1994; 2(2):77-82. PubMed ID: 8044659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of cystic fibrosis mutations in Israeli Jews.
    Orgad S; Neumann S; Loewenthal R; Netanelov-Shapira I; Gazit E
    Genet Test; 2001; 5(1):47-52. PubMed ID: 11336401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
    Peretz H; Mulai A; Usher S; Zivelin A; Segal A; Weisman Z; Mittelman M; Lupo H; Lanir N; Brenner B; Shpilberg O; Seligsohn U
    Blood; 1997 Oct; 90(7):2654-9. PubMed ID: 9326232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.
    Abeliovich D; Lavon IP; Lerer I; Cohen T; Springer C; Avital A; Cutting GR
    Am J Hum Genet; 1992 Nov; 51(5):951-6. PubMed ID: 1384328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs.
    Lerer I; Cohen S; Chemke M; Sanilevich A; Rivlin J; Golan A; Yahav J; Friedman A; Abeliovich D
    Hum Genet; 1990 Sep; 85(4):416-7. PubMed ID: 1976595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.
    Shoshani T; Augarten A; Gazit E; Bashan N; Yahav Y; Rivlin Y; Tal A; Seret H; Yaar L; Kerem E
    Am J Hum Genet; 1992 Jan; 50(1):222-8. PubMed ID: 1370365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic modification strategy of the Israeli carrier screening protocol: inclusion of the Oriental Jewish Group to the cystic fibrosis panel.
    Reish O; Borochowitz ZU; Adir V; Shohat M; Karpati M; Shtorch A; Orr-Urtreger A; Yaron Y; Shalev S; Fares F; Gershoni-Baruch R; Falik-Zaccai TC; Chapman-Shimshoni D
    Genet Med; 2009 Feb; 11(2):101-3. PubMed ID: 19265749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis mutations delta F508 and G542X in Jewish patients.
    Lerer I; Sagi M; Cutting GR; Abeliovich D
    J Med Genet; 1992 Feb; 29(2):131-3. PubMed ID: 1377276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups.
    Stoffman N; Magal N; Shohat T; Lotan R; Koman S; Oron A; Danon Y; Halpern GJ; Lifshitz Y; Shohat M
    Eur J Hum Genet; 2000 Apr; 8(4):307-10. PubMed ID: 10854115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
    Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
    Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews.
    Peleg L; Karpati M; Gazit E; Raas-Rothschild A; Goldman B
    Biochem Med Metab Biol; 1994 Jun; 52(1):22-6. PubMed ID: 7917464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations.
    Nakai K; Habano W; Nakai K; Fukushima N; Suwabe A; Moriya S; Osano K; Gurwitz D
    Life Sci; 2005 Nov; 78(1):107-11. PubMed ID: 16111713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel.
    Daniels M; Shohat T; Brenner-Ullman A; Shohat M
    Am J Med Genet; 1995 Jan; 55(3):311-4. PubMed ID: 7726228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.
    Tamary H; Bar-Yam R; Shalmon L; Rachavi G; Krostichevsky M; Elhasid R; Barak Y; Kapelushnik J; Yaniv I; Auerbach AD; Zaizov R
    Br J Haematol; 2000 Oct; 111(1):338-43. PubMed ID: 11091222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.
    Sereth H; Shoshani T; Bashan N; Kerem BS
    Hum Genet; 1993 Oct; 92(3):289-95. PubMed ID: 7691712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
    Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
    Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.